Thirty two oncogenes with >10% NSCLC patients having copy number gains.
收藏数据链接：
官方服务：
资源简介：
*P values were calculated to test the significance of observing the percentage (%) of patients with copy number gains (copy number ≥2.7) on the oncogenes, given that the null probability of copy number gains is 0.076, which is empirically estimated from the data.
创建时间：
2015-12-02
